Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-20-116128
Filing Date
2020-10-19
Accepted
2020-10-19 17:09:12
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-1 tm2033419d1_s1.htm S-1 305944
2 EXHIBIT 1.1 tm2033419d1_ex1-1.htm EX-1.1 248172
3 EXHIBIT 4.10 tm2033419d1_ex4-10.htm EX-4.10 215143
4 EXHIBIT 5.1 tm2033419d1_ex5-1.htm EX-5.1 11727
5 EXHIBIT 23.1 tm2033419d1_ex23-1.htm EX-23.1 2520
6 GRAPHIC tm20334119d1_ex5-1img.jpg GRAPHIC 12212
7 GRAPHIC tm2033419-1_s1img01.jpg GRAPHIC 12900
  Complete submission text file 0001104659-20-116128.txt   819422
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-249550 | Film No.: 201246757
SIC: 2836 Biological Products, (No Diagnostic Substances)